You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Acquired resistance to immunotherapy and future challenges
|
|---|---|
| Published in |
Nature Reviews Cancer, January 2016
|
| DOI | 10.1038/nrc.2016.2 |
| Pubmed ID | |
| Authors |
Nicholas P. Restifo, Mark J. Smyth, Alexandra Snyder |
| Abstract |
Advances in immunotherapy have resulted in remarkable clinical responses in some patients. However, one of the biggest challenges in cancer therapeutics is the development of resistant disease and disease progression on or after therapy. Given that many patients have now received various types of immunotherapy, we asked three scientists to give their views on the current evidence for whether acquired resistance to immunotherapy exists in patients and the future challenges posed by immunotherapy. |
X Demographics
The data shown below were collected from the profiles of 38 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 14 | 37% |
| France | 2 | 5% |
| Canada | 2 | 5% |
| Saudi Arabia | 1 | 3% |
| Tanzania, United Republic of | 1 | 3% |
| United Kingdom | 1 | 3% |
| Israel | 1 | 3% |
| Spain | 1 | 3% |
| Algeria | 1 | 3% |
| Other | 0 | 0% |
| Unknown | 14 | 37% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 20 | 53% |
| Scientists | 13 | 34% |
| Practitioners (doctors, other healthcare professionals) | 4 | 11% |
| Science communicators (journalists, bloggers, editors) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 572 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 7 | 1% |
| France | 3 | <1% |
| United Kingdom | 2 | <1% |
| Italy | 1 | <1% |
| Sweden | 1 | <1% |
| Denmark | 1 | <1% |
| Germany | 1 | <1% |
| Spain | 1 | <1% |
| China | 1 | <1% |
| Other | 0 | 0% |
| Unknown | 554 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 127 | 22% |
| Student > Ph. D. Student | 113 | 20% |
| Student > Master | 59 | 10% |
| Student > Bachelor | 50 | 9% |
| Other | 42 | 7% |
| Other | 94 | 16% |
| Unknown | 87 | 15% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 122 | 21% |
| Agricultural and Biological Sciences | 101 | 18% |
| Medicine and Dentistry | 95 | 17% |
| Immunology and Microbiology | 60 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 18 | 3% |
| Other | 77 | 13% |
| Unknown | 99 | 17% |
Attention Score in Context
This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 April 2022.
All research outputs
#1,324,007
of 23,577,654 outputs
Outputs from Nature Reviews Cancer
#464
of 2,346 outputs
Outputs of similar age
#24,965
of 399,701 outputs
Outputs of similar age from Nature Reviews Cancer
#7
of 41 outputs
Altmetric has tracked 23,577,654 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,346 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.5. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 399,701 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.